EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Germline analysis of an international cohort of pediatric diffuse midline glioma patients

Marion K Mateos iD, Pamela Ajuyah, Noemi Fuentes-Bolanos iD, Sam El-Kamand iD, Paulette Barahona, Ann-Kristin Altekoester, Chelsea Mayoh, Holly Holliday, Jie Liu, Louise Cui, Elke Pfaff iD, Alan Mackay und 26 weitere

Neuro-Oncology · 2025

DOI: 10.1093/neuonc/noaf061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Marion K Mateos und 37 weiteren Autor:innen. Beteiligte Einrichtung: Children's Cancer Institute Australia, Lowy Cancer Research Centre, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Germ-Line Mutation, Glioma, Genetic Predisposition to Disease, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MRFF, ALCCRF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Factors that drive the development of diffuse midline gliomas (DMG) are unknown. Our study aimed to determine the prevalence of pathogenic/likely pathogenic (P/LP) germline variants in pediatric patients with DMG.

Methods

We assembled an international cohort of 252 pediatric patients with DMG, including diffuse intrinsic pontine glioma (n = 153), with germline whole genome or whole exome sequencing.

Results

We identified P/LP germline variants in cancer predisposition genes in 7.5% (19/252) of patients. Tumor profiles differed, with the absence of somatic drivers in the PI3K/mTOR pathway in patients with germline P/LP variants versus those without (P = .023). P/LP germline variants were recurrent in homologous recombination (n = 9; BRCA1, BRCA2, PALB2) and Fanconi anemia genes (n = 4). Somatic findings established that the germline variants definitively contributed to tumorigenesis in at least 1% of cases. One patient with recurrent DMG and pathogenic germline variants (BRCA2, FANCE) showed a near-complete radiological response to PARP and immune checkpoint inhibition.

Conclusions

Our study determined the prevalence of pathogenic germline variants in pediatric DMG and suggests a role in tumorigenesis for a subset of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Germ-Line MutationGliomaGenetic Predisposition to DiseaseBrain NeoplasmsBiomarkers, TumorHumansChildMaleFemaleChild, PreschoolAdolescentCohort StudiesPrognosisInfantFollow-Up StudiesExome Sequencing

Stichwörter der Autor:innen

PARP inhibitordiffuse midline gliomagermline variantshomologous recombinationpediatric

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Children's Cancer Institute Australia, Lowy Cancer Research Centre, Sydney, New South Wales, Australia.
  • School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, New South Wales, Australia.
  • Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.
  • Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
  • German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Germany.

ORCID-Profile: Marion K Mateos, Noemi Fuentes-Bolanos, Sam El-Kamand, Elke Pfaff, Adam C Resnick, Catherine Goudie, David T W Jones, Nada Jabado, Maria Tsoli, Sebastian M Waszak, David S Ziegler

Förderung

  • MRFF
  • ALCCRF

Zitieren

APA

Mateos, M. K., Ajuyah, P., Fuentes-Bolanos, N., El-Kamand, S., Barahona, P., Altekoester, A. K., Mayoh, C., Holliday, H., Liu, J., Cui, L., Pfaff, E., Mackay, A., Resnick, A. C., Pinese, M., Lau, L. M. S., Khuong-Quang, D. A., Dias, K., Goudie, C., Salkeld, A., …, & Ziegler, D. S. (2025). Germline analysis of an international cohort of pediatric diffuse midline glioma patients. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf061

Vancouver

Mateos MK, Ajuyah P, Fuentes-Bolanos N, El-Kamand S, Barahona P, Altekoester AK, et al. Germline analysis of an international cohort of pediatric diffuse midline glioma patients. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf061

BibTeX
@article{Mateos2025,
  author = {Mateos, Marion K and Ajuyah, Pamela and Fuentes-Bolanos, Noemi and El-Kamand, Sam and Barahona, Paulette and Altekoester, Ann-Kristin and Mayoh, Chelsea and Holliday, Holly and Liu, Jie and Cui, Louise and Pfaff, Elke and Mackay, Alan and Resnick, Adam C and Pinese, Mark and Lau, Loretta M S and Khuong-Quang, Dong-Anh and Dias, Kimberly and Goudie, Catherine and Salkeld, Alison and Rokita, Jo Lynne and Jones, David T W and Juretic, Nikoleta and Hayden, Elisha and Pfister, Stefan M and Kramm, Christof M and Blattner-Johnson, Mirjam and Jabado, Nada and Tsoli, Maria and Vittorio, Orazio and Mueller, Sabine and Guo, Yiran and Tucker, Katherine and Waszak, Sebastian M and Perreault, Sebastien and Jones, Chris and Wong-Erasmus, Marie and Cowley, Mark J and Ziegler, David S},
  title = {Germline analysis of an international cohort of pediatric diffuse midline glioma patients},
  journal = {Neuro-Oncology},
  year = {2025},
  doi = {10.1093/neuonc/noaf061}
}
Kostenlos starten →